Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
Sinovac Biotech Enterprise Value: -6.942B for Dec. 20, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| China Pharma Holding Inc | 6.582M |
| CASI Pharmaceuticals Inc | 39.28M |
| Zai Lab Ltd | 2.370B |
| Adagene Inc | 15.17M |
| LakeShore Biopharma Co Ltd | 101.75M |
Enterprise Value Related Metrics
| Earnings Yield | -20.25% |
| Normalized Earnings Yield | -10.50 |